Journal Guide

This reader-friendly resource provides a powerful, broad-based perspective on the most important advances from throughout the world literature. Featuring renowned guest editors and focusing exclusively on one or two topics, every issue of Current Opinion in Endocrinology, Diabetes and Obesity delivers unvarnished, expert assessments of developments from the previous year. All reviews are supplemented with an indispensable section,References and Recommended Reading. At the back of each volume is Current World Literature, an exceptionally thorough bibliography culled from hundreds of top journals in the field.Website:www.co-endocrinology.com.

American Heart Association members are eligible for a 20% discount on subscription rates.This reader-friendly, bimonthly resource provides a powerful, broad-based perspective on the most important advances from throughout the world literature. Featuring renowned guest editors and focusing exclusively on one topic, every issue of Current Opinion in Lipidology delivers unvarnished, expert assessments of developments from the previous year. All reviews are supplemented with an indispensable section, 'References and Recommended Reading'. At the back of each volume is 'Current World Literature', an exceptionally thorough bibliography culled from the top 100 journals in the field.Website: www.co-lipidology.com.

This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of osteoporosis.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as current and future therapeutics, epidemiology and pathophysiology, and evaluation and management. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

Cytokine & Growth Factor Reviews publishes thought-provoking articles (critical reviews, state-of-the-art reviews, letters to the editor, meeting reviews) devoted to important advances in the rapidly changing fields of growth factor and cytokine research. Major emphasis is placed on the multidisciplinary significance of cytokines and growth factors in areas as diverse as signal transduction, cell growth and differentiation, embryonic development, immunology, tumorigenesis and clinical medicine.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published.

The aims and objectives of Diabetes and Metabolic Syndrome: Clinical Research and Reviews are to increase knowledge, provide guidelines and policies, stimulate research about the physiology and pathophysiology, and to promote better management of the metabolic diseases, using peer-reviewed original articles and expert comments. It encourages the publication of original basic/original research articles, reviews, short communication, case reports and letters. Reviews or mini-reviews are especially welcomed for those areas within endocrinology undergoing rapid changes. Short communications should contain concise definitive information.

A high quality scientific journal with an international readershipOfficial publication of the Alfediam, Diabetes & Metabolism, publishes high-quality papers by leading teams, forming a close link between hospital and research units. Diabetes & Metabolism is published in English language and is indexed in all major databases with its impact factor up to 2.426 in 2010 (IF 2009).Diabetes & Metabolism contains original articles, short reports and comprehensive reviews. The latter are updates written by internationally recognized specialists carefully edited in order to help clinicians and researchers keep informed about the latest developments in the field of diabetes.Une revue scientifique de haute qualitéDiabetes & Metabolism réunit des articles originaux, des cas cliniques, des lettres à l'éditeur et des travaux indispensables pour la compréhension du diabète et de ses conséquences multiples, ainsi que des Recommandations de l'Alfediam. Elle est destinée aux cliniciens et aux chercheurs qui souhaitent suivre de près les récentes évolutions de la diabétologie.Une revue à diffusion internationaleDiabetes & Metabolism publie en langue anglaise les travaux des meilleures équipes francophones et étrangères de la spécialité et rencontre un facteur d'impact qui ne cesse de progresser. La revue est indexée dans les plus grandes bases de données internationales : Current Contents (Life Sciences), EMBASE (Excerpta Medica), Research Alert, SCI Search.

Diabetes Care is a journal for the health care practitioner that is intended to increase knowledge, stimulate research, and promote better management of people with diabetes. To achieve these goals, the journal publishes original research on human studies in the following five categories: 1) Clinical Care/Education/Nutrition/Psychosocial Research, 2) Epidemiology/Health Services Research, 3) Emerging Treatments and Technologies, 4) Pathophysiology/Complications, and 5) Cardiovascular and Metabolic Risk. The journal also publishes clinically relevant review articles, letters to the editor, and health/medical news or points of view. Topics covered are of interest to clinically oriented physicians, researchers, epidemiologists, psychologists, diabetes educators, and other health professionals. .

Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.Diabetes Research and Clinical Practice is the official journal of the International Diabetes Federation.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The mission of Diabetes Spectrum: From Research to Practice is to assist health care professionals in the development of strategies to individualize treatment and diabetes self-management education for improved quality of life and diabetes control. These goals are achieved by presenting review as well as original, peer-reviewed articles on topics in clinical diabetes management, professional and patient education, nutrition, behavioral science and counseling, educational program development, and advocacy. In each issue, the FROM RESEARCH TO PRACTICE section explores, in depth, a diabetes care topic and provides practical application of current research findings.

Diabetes Technology & Therapeutics is the only peer-reviewed journal which provides healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of the latest technologies and therapeutics in the field. Each issue highlights new pharmacological and device developments to optimize patient care. The Journal fosters the development and use of new and emerging technologies to be applied to diabetes, including: Alternate insulin delivery methods Continuous glucose monitoring Artificial pancreas Computerized case management/telemedicine Detection and prevention of long-term micro- and macrovascular complicationsThe Journal publishes recent developments in pharmacologic therapy and device development with original papers, accompanied by analysis commentaries, on the performance of brand-name products.

Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title.It mirrors the increasing recognition that diabetes and cardiovascular disease are a single entity in which diabetes and related disorders such as insulin resistance Diabetes & Vascular Disease Researchare directly linked with assaults on the vessel wall and the development of vascular risk clustering.Diabetes & Vascular Disease Research:· Links diabetes, its metabolic consequences and vascular outcomes·Original research in fields of insulin resitance and metabolic disorders· Promotes understand of pathology, aetiology and management of Thrombosis, Hyperglycaemia, Hypertension, Dyslipidaemia and Micro-and macrovascular consequences.

Diabetes, Obesity & Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. 'Metabolism' may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.

Diabetes/Metabolism Research and Reviews is an indispensable resource for clinicians and researchers working in the fields of diabetes, endocrinology, metabolism and obesity. Our reviews section provides the latest updates on clinical and basic scientific advances in key areas of diabetes, obesity and metabolism, important historical overviews, discussion of controversial issues and opinions from prominent researchers and clinicians. Original articles describing clinical studies, translational and basic research related to diabetes, obesity, metabolism, or closely related metabolic disorders are welcome, as are articles concerned with treatment and management issues related to patient care.Please note that Diabetes/Metabolism Research and Reviews is an online-only journal.Benefits for our authors:* No charges for colour figures* Accepted article PDFs are published within days of acceptance* Faster issue publication times for full final articles* Better integration of online supporting information for articlesDiabetes/Metabolism Research and Reviews publishes supplements. If you are interested in publishing a supplement, please visit our Contact page and select your region in the Advertising and Corporate Sales section.

Diabetic Medicine, one of the leading clinical diabetes journals in the world, publishes comprehensive reviews and original articles on clinical research and practice in diabetes. Issues also regularly include case reports, editorials, comment, news and correspondence. All material is peer-reviewed as the journal seeks to provide a forum for the exchange of information between clinicians and researchers worldwide and all health professionals responsible for the care of people with diabetes.

Diabetologia publishes original clinical and experimental research within the field of diabetes. We are interested in papers that convey new information or insight into any aspect of the condition, ranging from basic science to clinical applications. These are judged in terms of their scientific quality, novelty, relevance and interest to our broadly based readership. Diabetologia also hosts editorials, commentaries, debates and reviews, relating to any aspect of diabetes and related conditions, and welcomes submissions from any part of the world. For more information about the journal, including instructions to authors, see www.diabetologia-journal.org.